155 related articles for article (PubMed ID: 5527648)
1. [Clinical trial of nicamethate in psychogeriatrics].
Bianchi G
Clin Ter; 1970 Sep; 54(6):541-52. PubMed ID: 5527648
[No Abstract] [Full Text] [Related]
2. [Tebonin in chronic cerebral ischemia].
Birkmayer W; Danielczyk W
Med Klin; 1967 Mar; 62(11):421-4. PubMed ID: 5586146
[No Abstract] [Full Text] [Related]
3. [Wallerox increases cerebral circulation and heart capacity].
Heynen U
Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
[No Abstract] [Full Text] [Related]
4. [Conservative treatment of cerebral insufficiency. Experiences with wallerox].
Poser G
Munch Med Wochenschr; 1971 May; 113(19):738-41. PubMed ID: 4995708
[No Abstract] [Full Text] [Related]
5. [Vasoactive combination treatment in cerebrovascular sclerosis].
Klein K
Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190
[No Abstract] [Full Text] [Related]
6. Clinical experiments with brain cortex phospholipids in psychogeriatrics.
Castellani A; Colafelice M; Perbellini D; Fichera M; Carbognin G; Salvi G; Marsiai M; Rigoli GF
Acta Neurol (Napoli); 1978; 33(3):217-29. PubMed ID: 747138
[No Abstract] [Full Text] [Related]
7. [Cosaldon in the treatment of cerebral arteriosclerosis].
Dzialek E; Orzechowska-Wolczyk M; Zawadzki Z
Wiad Lek; 1975 Sep; 28(18):1547-9. PubMed ID: 1163042
[No Abstract] [Full Text] [Related]
8. [Therapy of cerebral sclerosis from the viewpoint of the practitioner].
Orth H
Z Allgemeinmed; 1970 May; 46(15):800-5. PubMed ID: 5522943
[No Abstract] [Full Text] [Related]
9. [On the treatment of cerebral nutrition disorders. A double blind study].
Kirchberger F; Kehl R; Gutmann W
Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
[No Abstract] [Full Text] [Related]
10. [Improved cerebral circulation and increment performance in a psychologic experiment].
Köhler W
Nervenarzt; 1970 Apr; 41(4):181-7. PubMed ID: 4914870
[No Abstract] [Full Text] [Related]
11. [Cerebral angiodynamic effects of nicotinic acid in man. (Polygraphic and angiographic studies)].
Corsi C; Spinelli P
Rass Neurol Veg; 1967 Dec; 21(6):337-52. PubMed ID: 5608551
[No Abstract] [Full Text] [Related]
12. Hydergine for cerebral arteriosclerosis.
Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
[No Abstract] [Full Text] [Related]
13. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
Bornstein S; Sère de Rivières H
Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366
[No Abstract] [Full Text] [Related]
14. [Polygraphic evaluation of a new vasoactive drug (nicergoline)].
Baturic P; Cirignotta F
Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189
[No Abstract] [Full Text] [Related]
15. Triflupromazine versus pentylenetetrazol-nicotinic acid for treatment of chronic brain disease on a general-hospital psychiatric service.
Danto BL
J Am Geriatr Soc; 1969 Apr; 17(4):414-20. PubMed ID: 5774873
[No Abstract] [Full Text] [Related]
16. [Drug therapy of cerebral arteriosclerosis in the senile age].
Mankovsky N; Mints A
G Gerontol; 1972 Jan; 20(1):42-9. PubMed ID: 5023587
[No Abstract] [Full Text] [Related]
17. [On the use of thioridazine in psychogeriatrics].
Ragonese G; Chimenz B; Cannavò A
Rass Neuropsichiatr; 1966; 20(3):413-8. PubMed ID: 5999688
[No Abstract] [Full Text] [Related]
18. [Specific range of action of a new gerontotherapeutic agent. Psychopharmacological and therapeutic study].
Oswald WD; Zeus L
Med Welt; 1969 Jun; 25():1439-44. PubMed ID: 4978450
[No Abstract] [Full Text] [Related]
19. A clinical trial of leptazole with nicotinic acid in the management of psycho-geriatric patients.
Gabrynowicz JW; Dumbrill M
Med J Aust; 1968 May; 1(19):799-802. PubMed ID: 4872367
[No Abstract] [Full Text] [Related]
20. [Clinico-experimental studies on decreasing blood lipids in geriatrics].
Bracharz H; Laas H
Med Monatsschr; 1966 Oct; 20(10):471-6. PubMed ID: 5978465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
